Microfluidic paclitaxel-loaded lipid nanoparticle formulations for chemotherapy

被引:30
|
作者
Jaradat, Eman [1 ]
Weaver, Edward [1 ]
Meziane, Adam [2 ]
Lamprou, Dimitrios A. [1 ]
机构
[1] Queens Univ Belfast, Sch Pharm, 97 Lisburn Rd, Belfast BT9 7BL, North Ireland
[2] Fluigent, F-94270 Le Kremlin Bicetre, France
关键词
Microfluidics; Nanomedicine; Nanoparticles; Emerging technologies; Liposomes; Paclitaxel; Chemotherapy; Cancer; DRUG-DELIVERY-SYSTEMS; BREAST-CANCER; IN-VITRO; LIPOSOMES; ENCAPSULATION; CHOLESTEROL; SIZE; SPECTROSCOPY; TEMPERATURE; INTERFACE;
D O I
10.1016/j.ijpharm.2022.122320
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nanoparticle technology has promising effects on multiple therapeutic purposes, particularly in controlling drug delivery as Drug Delivery System. The unique properties of nanoparticles significantly enhance drug delivery, efficiency, and toxicity. For cancer therapy, controlling chemotherapy delivery can increase the drug concen-tration in the desired locations, improve drug efficacy, and limit drug toxicity. Liposomes are used in this project to encapsulate paclitaxel due to their ability to carry hydrophobic molecules, low toxicity, and prolonged half-life. Among the multiple liposome preparation methods, microfluidic technology was used to produce liposomes. Microfluidics excels in other conventional methods by offering a high-level control of the process's parameters, which help control particle size, size distribution, and physiochemical properties. This project aims to produce paclitaxel-loaded liposomes with a diameter below 200 nm with low polydispersity index, high homogeneity, and good stability. Different lipid types (DMPC, DPPC, DSPC, and DOPC) were used with different ratios to investigate their impact on empty liposome formulation. Alongside changing the different microfluidic param-eters including the total flow ratio and flow rate ratio to study their effects on liposomes' physiochemical properties. The obtained formulations were tested to analyse different physiochemical properties (DLS, FTIR) and stability studies. DMPC and DPPC are determined to study their encapsulation efficiency and in vitro drug release of paclitaxel at total flow rate 1 ml min-1 and 1:4 flow rate ratio. The paclitaxel-loaded liposomes are subjected to the same physiochemical characteristics and stability study. Promising encapsulation efficiency was reported from both DPPC and DMPC, and sustained drug release was observed.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Development of a hybrid paclitaxel-loaded arsenite nanoparticle (HPAN) delivery system for synergistic combined therapy of paclitaxel-resistant cancer
    Chen, Fei-yan
    Zhang, Yu
    Chen, Xiang-yu
    Li, Jia-qian
    Xiao, Xiao-ping
    Yu, Lu-lu
    Tang, Qun
    JOURNAL OF NANOPARTICLE RESEARCH, 2017, 19 (04)
  • [42] Development of a hybrid paclitaxel-loaded arsenite nanoparticle (HPAN) delivery system for synergistic combined therapy of paclitaxel-resistant cancer
    Fei-yan Chen
    Yu Zhang
    Xiang-yu Chen
    Jia-qian Li
    Xiao-ping Xiao
    Lu-lu Yu
    Qun Tang
    Journal of Nanoparticle Research, 2017, 19
  • [43] Preparation and evaluation of paclitaxel-loaded nanoparticle incorporated with galactose-carrying polymer for hepatocyte targeted delivery
    Wang, Yujie
    Jiang, Guoqiang
    Qiu, Tingting
    Ding, Fuxin
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2012, 38 (09) : 1039 - 1046
  • [44] Synthesis, Structural Characterization, and Preclinical Efficacy of a Novel Paclitaxel-Loaded Alginate Nanoparticle for Breast Cancer Treatment
    Markeb, Ahmed A.
    El-Maali, Nagwa A.
    Sayed, Douaa M.
    Osama, Amany
    Abdel-Malek, Mohamed A. Y.
    Zaki, Amen H.
    Elwanis, Mostafa E. A.
    Driscoll, James J.
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2016, 2016
  • [45] Prevention of local tumor growth with paclitaxel-loaded microspheres
    Azouz, Solomon M.
    Walpole, Joseph
    Amirifeli, Sepideh
    Taylor, Kendra N.
    Grinstaff, Mark W.
    Colson, Yolonda L.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 135 (05): : 1014 - 1021
  • [46] Reexamining in vivo fate of paclitaxel-loaded polymeric micelles
    Lin, Shiqi
    Yu, Yifei
    Wu, Ercan
    Ding, Tianhao
    Chu, Yuxiu
    Pan, Feng
    Yang, Yang
    Zhan, Changyou
    NANO TODAY, 2024, 56
  • [47] In vitro and in vivo correlation of paclitaxel-loaded polymeric microparticles
    Park, Kinam
    JOURNAL OF CONTROLLED RELEASE, 2013, 172 (03) : 1162 - 1162
  • [48] Paclitaxel-loaded composite fibers: Microstructure and emulsion stability
    Kraitzer, Amir
    Zilberman, Meital
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2007, 81A (02) : 427 - 436
  • [49] Microfluidic formulation, cryoprotection and long-term stability of paclitaxel-loaded π electron-stabilized polymeric micelles
    Mihyar, Rahaf
    Shalmani, Armin Azadkhah
    Wildt, Viktor
    Sheybanifard, Maryam
    Wang, Alec
    May, Jan-Niklas
    Shahzad, Saba
    Buhl, Eva Miriam
    Ruetten, Stephan
    Behrens, Diana
    Waltherd, Wolfgang
    Tiboni, Mattia
    Casettari, Luca
    Buyel, Johannes F.
    Rijcken, Cristianne J. F.
    Hennink, Wim E.
    von Stillfried, Saskia
    Kiessling, Fabian
    Shi, Yang
    Metselaar, Josbert M.
    Lammers, Twan
    Pena, Quim
    JOURNAL OF CONTROLLED RELEASE, 2024, 375 : 614 - 626
  • [50] Paclitaxel-loaded multifunctional nanoparticles for the targeted treatment of glioblastoma
    Ganipineni, Lakshmi Pallavi
    Ucakar, Bernard
    Joudiou, Nicolas
    Riva, Raphael
    Jerome, Christine
    Gallez, Bernard
    Danhier, Fabienne
    Preat, Veronique
    JOURNAL OF DRUG TARGETING, 2019, 27 (5-6) : 614 - 623